Based on current clinical trial data, tirzepatide (Zepbound/Mounjaro) at the 15 mg dose produces the highest average weight loss approximately 2022% of body weight, or around 48 lbs on average in the SURMOUNT-1 trial
Consulting a tirzepatide online provider allows you to receive personalized gastrointestinal support and dosage adjustments to maintain optimal digestive health
In 2023, the FDA approved tirzepatide for obesity, which, according to Gratzl and colleagues, contributed to an increase in prescribing trends of GLP-1 medications
Join our newsletter for exclusive wellness tips, special offers, and updates
Yes, by supporting performance and energy production, creatine can help combat GLP-1-related fatigue during training